Lan Yin

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

RNF114-PACSIN3 signaling axis promotes hepatocellular carcinoma progression by enhancing GLUT1 membrane retention and glucose uptake.

RNF114-PACSIN3 signaling axis promotes hepatocellular carcinoma progression by enhancing GLUT1 membrane retention and glucose uptake.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: February 11, 2026

MRPL3 is identified as a prognostic biomarker and therapeutic target in lung adenocarcinoma via a lactylation-disulfidptosis gene signature model and experimental validation.

MRPL3 is identified as a prognostic biomarker and therapeutic target in lung adenocarcinoma via a lactylation-disulfidptosis gene signature model and experimental validation.

Journal: Frontiers in immunology

Published: December 22, 2025

A novel tumor-associated macrophage risk signature predicts prognosis and immunotherapy response in lung adenocarcinoma.

A novel tumor-associated macrophage risk signature predicts prognosis and immunotherapy response in lung adenocarcinoma.

Journal: American journal of cancer research

Published: January 07, 2025

RNF114 Interacts with EWSR1 to Regulate VEGFR2 in HER2-positive Breast Cancer.

RNF114 Interacts with EWSR1 to Regulate VEGFR2 in HER2-positive Breast Cancer.

Journal: Journal of Cancer

Published: October 29, 2024

A novel prognostic model based on migrasome-related LncRNAs for gastric cancer.

A novel prognostic model based on migrasome-related LncRNAs for gastric cancer.

Journal: Scientific reports

Published: October 27, 2024

Analyzing immune cell infiltrates in skeletal muscle of infantile-onset Pompe disease using bioinformatics and machine learning.

Analyzing immune cell infiltrates in skeletal muscle of infantile-onset Pompe disease using bioinformatics and machine learning.

Journal: Scientific reports

Published: May 02, 2024

PKM2 is a potential prognostic biomarker and related to immune infiltration in lung cancer.

PKM2 is a potential prognostic biomarker and related to immune infiltration in lung cancer.

Journal: Scientific reports

Published: October 09, 2023

Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.

Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.

Journal: Journal of translational medicine

Published: December 19, 2022

Functional characterization of a rare pathogenic variant c.875G > A, p.(Cys292Tyr) in COMP.

Functional characterization of a rare pathogenic variant c.875G > A, p.(Cys292Tyr) in COMP.

Journal: Annals of human genetics

Published: October 26, 2022

A novel NPHS2 mutation (c.865A > G) identified in a Chinese family with steroid-resistant nephrotic syndrome alters subcellular localization of nephrin.

A novel NPHS2 mutation (c.865A > G) identified in a Chinese family with steroid-resistant nephrotic syndrome alters subcellular localization of nephrin.

Journal: Genes & genomics

Published: November 01, 2021

Heat Shock Protein 90 Triggers Multi-Drug Resistance of Ovarian Cancer via AKT/GSK3β/β-Catenin Signaling.

Heat Shock Protein 90 Triggers Multi-Drug Resistance of Ovarian Cancer via AKT/GSK3β/β-Catenin Signaling.

Journal: Frontiers in oncology

Published: October 24, 2020

FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer.

FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer.

Journal: Aging

Published: May 21, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026